City

Linkoping (1)

Lund (1)

Stockholm (1)

Varberg (1)

Winston-Salem (1)

Overall Status

Recruiting (2)

Not yet recruiting (1)

Sign in for free

Phase

n/a (1)

phase 4 (1)

Sponsor

China National Center for Cardiovascular Diseases (1)

Region Skane (1)

Wake Forest University Health Sciences (1)

Collaborator

National Heart, Lung, and Blood Institute (NHLBI) (1)

Intervention

atrial fibrillation ablation by pulmonary vein isolation (1)

empagliflozin 10 mg (1)

his-bundle pacing and av node ablation (1)

placebo (1)

Study Documents

Intervention Type

drug (1)

procedure (1)

Funder Type

Other (3)

Study Type

Interventional (2)

Observational (1)

left atrial dilatation

Showing 1 - 3 of 3

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

LAST UPDATED

Heart Failure, Hypertension, Left Ventricle Remodeling Trial (Empagliflozin 10 MG, Placebo)

Not yet recruiting

Heart Failure
+3 more

Empagliflozin 10 MG
Placebo

(no location specified)

Sep 20, 2023

Pediatric Hypertension and the Renin-Angiotensin SystEm (PHRASE)

Recruiting

Hypertension
+17 more

Winston-Salem, North Carolina

Wake Forest Health Sciences

Jan 3, 2023

Atrial Fibrillation, Left Atrial Dilatation Trial in Sweden (His-bundle pacing and AV node ablation, Atrial fibrillation

Recruiting

Atrial Fibrillation
Left Atrial Dilatation

His-bundle pacing and AV node ablation
Atrial fibrillation ablation by pulmonary vein isolation

Linköping, Sweden
+3 more

Jan 7, 2022